Information Provided By: 
Fly News Breaks for February 22, 2018
SRCL
Feb 22, 2018 | 07:35 EDT
RBC Capital analyst Gary Bisbee lowered his price target on Stericycle to $61 and kept his Underperform rating following the company's Q4 earnings and FY18 guidance. Bisbee says the outlook suggests that weaker revenue, cost pressures, and investments will weigh on earnings and cash flow, adding that he has little confidence in the company's execution.
News For SRCL From the Last 2 Days
SRCL
Apr 25, 2024 | 07:04 EDT
Completed previously disclosed workforce reduction in the first quarter of 2024 and are on track to realize an estimated $40-$45 million of in-year cost savings.
